Press releases | WebDisclosure

Basculer en Français

10965	Companies
240129	Keywords
168906	Articles
129229	Press releases

Home
Press releases

REGULATED PRESS RELEASE

published on 02/19/2026 at 18:00, 6 months 20 days ago

IMERYS_Press_Release_FY2025_ENG_19Feb2026_VF
PRESS RELEASE

published on 02/19/2026 at 18:00, 6 months 20 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing. Company specializes in acquiring European pharmaceutical subcontractors

Pharmaceutical Transparency Notification Shareholding Oxurion NV European Subcontractors
PRESS RELEASE

published on 02/19/2026 at 18:00, 6 months 20 days ago

RÉSULTATS SEMESTRIELS 2025-26 À L'ÉQUILIBRE
Miliboo publie des résultats semestriels solides : croissance du CA de +6,6%, marge brute à 60,6%, EBITDA à l'équilibre. Situation financière renforcée par nouveaux emprunts

Croissance Résultats Semestriels EBITDA Situation Financière Miliboo
PRESS RELEASE

published on 02/19/2026 at 18:00, 6 months 20 days ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop van aandelen en specialiseert zich in farmaceutische onderaannemers

Transparantiekennisgeving Oxurion NV België Farmaceutische Onderaannemers Aandelenverkoop
PRESS RELEASE

published on 02/19/2026 at 18:00, 6 months 20 days ago

THX Pharma Reports Its Cash Position as of December 31, 2025
THX Pharma (Theranexus) announces cash position of €7.8 million as of Dec 31, 2025. Pro forma cash position reaches €21.7 million with incoming payment from Biocodex agreement. Company focused on rare neurological diseases treatments development

Cash Position Rare Neurological Diseases Therapeutic Solutions THX Pharma Biocodex Agreement
REGULATED PRESS RELEASE

published on 02/19/2026 at 18:00, 6 months 20 days ago

IMERYS_Communique-de-presse_RA2025_FR_19Fev2026_VF
REGULATED PRESS RELEASE

published on 02/19/2026 at 18:00, 6 months 20 days ago

IMERYS_Press_Release_FY2025_ENG_19Feb2026_VF
PRESS RELEASE

published on 02/19/2026 at 18:00, 6 months 20 days ago

THX Pharma publie sa position de trésorerie au 31 décembre 2025
THX Pharma annonce une trésorerie disponible de 7,764 k€ au 31 décembre 2025, renforcée par un accord avec Biocodex pour un versement de 12 M€ en mars 2026. Prochaine publication : Résultats financiers annuels le 28 avril 2026

Résultats Financiers Trésorerie Accord THX Pharma Biocodex
PRESS RELEASE

published on 02/19/2026 at 17:52, 6 months 20 days ago

Marie Brizard Wine & Spirits: Q4 2025 and full-year 2025 revenues
Marie Brizard Wine & Spirits reports FY 2025 revenues of €172.0m (-8.6% vs 2024) and Q4 2025 revenues of €44.6m (-6.9%). Global spirits market slowdown impacts sales, with French market hit by delistings

Revenues Marie Brizard Wine & Spirits Q4 2025 Global Spirits Market
PRESS RELEASE

published on 02/19/2026 at 17:52, 6 months 20 days ago

Marie Brizard Wine & Spirits: Activité du 4ème trimestre 2025 et de l’année 2025
Marie Brizard Wine & Spirits annonce une baisse de 8,6% de son chiffre d'affaires en 2025. Ralentissement du marché des spiritueux en France, amélioration de la performance aux États-Unis

Chiffre D'affaires Baisse France Spiritueux Marie Brizard

Accesswire

Published on 09/11/2026 at 23:00, 3 hours 24 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 4 hours 19 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 4 hours 59 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 9 hours 24 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 9 hours 24 minutes ago

Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan

View all ACCESSWIRE

EQS Group

Published on 09/11/2026 at 22:15, 4 hours 9 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 4 hours 14 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 6 hours 39 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 8 hours 9 minutes ago

CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:07, 8 hours 17 minutes ago

Holding(s) in Company

Les Echos

Published on 09/11/2026 at 07:00, 19 hours 24 minutes ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 19 hours 24 minutes ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 19 hours 24 minutes ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 19 hours 24 minutes ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 6 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE